These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2264405)

  • 1. [General prevention of osteoporosis--yes or no?].
    Göretzlehner G
    Zentralbl Gynakol; 1990; 112(14):865-6. PubMed ID: 2264405
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current status of estrogen and gestagen substitution in peri and postmenopause].
    Birkhäuser M
    Praxis (Bern 1994); 1997 Jan; 86(5):125-8. PubMed ID: 9064729
    [No Abstract]   [Full Text] [Related]  

  • 3. [Considerations on hormone replacement therapy].
    Pérez-Caballero MC; León MP; Gimeno LA; Abadía MB
    Med Clin (Barc); 1995 Apr; 104(12):477. PubMed ID: 7739287
    [No Abstract]   [Full Text] [Related]  

  • 4. Osteoporosis: prevention is key to management.
    Levin RM
    Geriatrics; 1993 Jun; 48 Suppl 1():18-24. PubMed ID: 8508962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on continuous estrogen-progestin replacement therapy.
    Rosenfeld JA
    Am Fam Physician; 1994 Nov; 50(7):1519-23, 1527-8. PubMed ID: 7976988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
    Josse RG
    CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Estrogen-gestagen substitution in geriatric gynecology. Long-term prevention for the third segment of life after menopause].
    Lauritzen C
    Fortschr Med; 1996 May; 114(15):187-90. PubMed ID: 8767936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Osteoporosis: prevention with postmenopausal hormonal substitution].
    Welti H
    Rev Med Suisse Romande; 1990 Jun; 110(6):565-9. PubMed ID: 2367794
    [No Abstract]   [Full Text] [Related]  

  • 9. Compliance with drug therapies for the treatment and prevention of osteoporosis.
    McCombs JS; Thiebaud P; McLaughlin-Miley C; Shi J
    Maturitas; 2004 Jul; 48(3):271-87. PubMed ID: 15207894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tamoxifen for osteoporosis prevention?].
    Obrecht JP
    Dtsch Med Wochenschr; 1989 Sep; 114(38):1465-6. PubMed ID: 2791897
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention of osteoporosis].
    Ziegler R
    Verh Dtsch Ges Inn Med; 1989; 95():313-9. PubMed ID: 2690502
    [No Abstract]   [Full Text] [Related]  

  • 12. [Role of the family doctor in the complex treatment of early and late consequences of postmenopause. Effect of estrogen-progestogen on osteoporosis].
    Farkas M
    Acta Pharm Hung; 1995 May; 65(3):77-89. PubMed ID: 7572188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy and osteoporosis.
    Drury R
    Ir Med J; 1997 Oct; 90(6):214, 216. PubMed ID: 9611918
    [No Abstract]   [Full Text] [Related]  

  • 14. Menopause: estrogen replacement, osteoporosis, and serum lipoproteins.
    Gnatuk CL; Ory SJ
    Curr Opin Obstet Gynecol; 1989 Dec; 1(2):187-94. PubMed ID: 2491121
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevention of osteoporosis--why? Who? How?].
    Siggelkow H; Hüfner M
    Med Klin (Munich); 1995 Nov; 90(11):639-44. PubMed ID: 8569632
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of osteoporosis is still a valid aim for hormone therapy.
    Sturdee DW; Maclennan AH
    Climacteric; 2005 Jun; 8(2):97-8. PubMed ID: 16096165
    [No Abstract]   [Full Text] [Related]  

  • 17. The prevention of osteoporosis: current considerations.
    Fulton JP; Laufer D; Miller MA; Hamel DE
    Med Health R I; 1997 Nov; 80(11):376-8. PubMed ID: 9385799
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hormone replacement therapy in peri- and postmenopause. Routine use is not indicated].
    Emons G; Westphalen S
    MMW Fortschr Med; 2002 Feb; 144(9):30-3. PubMed ID: 11921648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progestins and recurrence in breast cancer survivors.
    Chlebowski RT; Anderson GL
    J Natl Cancer Inst; 2005 Apr; 97(7):471-2. PubMed ID: 15812065
    [No Abstract]   [Full Text] [Related]  

  • 20. [Application of new therapeutic approaches in the prevention of osteoporosis in women].
    Bocci A; Campagnoli C; Ardizzoia M
    Minerva Endocrinol; 1989; 14(1):75-80. PubMed ID: 2733648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.